Creso Pharma Stock (OTCMKTS:COPHF)


$ 0.06
Today's Range
$ 0.06 - $ 0.06
52-Week Range
$ 0.02 - $ 0.12
Market Cap
$ 48.22M

About Creso Pharma (OTCMKTS:COPHF)


Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, and the Asia Pacific. The company is involved in hemp growing operations, outsourced CBD extraction, and cannabidiol (CBD) product sales activities, as well as the development and commercialization of its therapeutic products. Its products include anibidiol, a natural complementary feed product for companion animals; and cannaQIX, a nutraceutical product containing organic hemp extract with CBD vitamins and zinc to reduce stress and support mental and nervous functions in humans, as well as topical and skin care products. The company also offers various nutraceutical products, such as cannaQIX®nite to aid sleep; cannaPEAL to introduce various markets to the benefits of hemp seed oil-based products; and cannaDOL to provide relief to athletes in the form of a topical application. In addition, it imports and sells its medicinal cannabis product, cannaQIX50 to patients in Brazil. Creso Pharma Limited has a strategic collaboration agreement with Hempmate AG Switzerland and Burleigh Heads Cannabis Pty Ltd. The company was incorporated in 2015 and is headquartered in Sydney, Australia.

Show more

COPHF Stock Price

Statistics Highlights (OTCMKTS:COPHF)

Shares Outstanding 1.40B Beta 3.38
Public Float 968.22M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 24.91% Ex-Dividend Date
Held by Institutions 2.86% IPO Date -

COPHF Financial Summary

Dec 21 Dec 20 Dec 19
Revenue $6.22M $2.45M $3.63M
EBITDA $-28.06M $-21.16M $-12.85M
Net Income $-30.03M $-30.78M $-15.05M
Total Assets $29.31M $19.12M $22.66M
Total Cash $7.18M $6.05M $2.80M
Total Debt $ $ $
Dec 21 Sep 21 Jun 21
Revenue $ $ $
EBITDA $ $ $
Net Income $ $ $
Total Assets $29.31M $ $
Total Cash $7.18M $ $
Total Debt $ $ $


What is today's stock price of Creso Pharma (OTCMKTS:COPHF)?

  • The current stock price of Creso Pharma (OTCMKTS:COPHF) is $0.06.
  • Today COPHF stock price opened at $0.06 after previous close of $0.06.
  • During the day, Creso Pharma stock quote has varied from a low of $0.06 to a high of $0.06.

What is Creso Pharma's 52-week change?

  • COPHF 52-week high stock quote is $0.12, which is 88.70% above the current share price.
  • The Creso Pharma (OTCMKTS:COPHF) 52-week low stock price is $0.02, which is 70.60% below the current share price.
  • Creso Pharma share price volatility (52-week beta) is 3.38.


How Much is Creso pharma Worth?

Creso pharma's worth today based on market capitalisation is $48.22M

How much dividend does Creso pharma Pay?

The current annualized dividend payout for COPHF stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Creso pharma's "Dividend" Section

What is Creso pharma’s Price to Earning (PE) ratio?

COPHF stock also has a Price to Sales (P/S) ratio of 7.19.

What is the Creso pharma's ticker?

Creso pharma trades on the OTC Markets stock market in USA under the ticker symbol "COPHF". Creso pharma’s stock symbol can also be displayed as "OTCMKTS:COPHF".

Who are the owners of Creso pharma?

Creso pharma (OTCMKTS:COPHF) is owned by 2.85% institutional shareholders and by 24.91% insiders. The rest is owned by the public.
Explore More Details on Creso pharma's “Ownership” Section

Who are the key executives of Creso pharma (COPHF)?

Creso pharma's key executive team includes the following managers:

  • Dr. James Anthony Ellingford AICD, D.Mgt, M.B.A., MBA, PG(Corp Mgmt), Ph.D., Exec. Chairman (NA)
  • Mr. Boaz Wachtel M.A., M.D., MBA, Co-Founder & Non-Exec. Director (1961)
  • Mr. Adam Blumenthal B.Com., M.B.A., Co-Founder & Non-Exec. Director (NA)
  • Mr. Christopher Grundy, Chief Financial Officer (NA)
  • Mr. William Lay B.Com., Group CEO, MD & Director (NA)
  • Dr. Gian Trepp, Commercial & Marketing Director (NA)
  • Ms. Micheline MacKay B.Sc., M.Sc., P.M.P., MD & Exec. Director (NA)
  • Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACG, Joint Company Sec. (NA)
  • Mr. Winton William Willesee C.P.A., GAICD, MAICD, MCom, Joint Company Sec. (1970)
  • Dr. Simon H. W. Buckingham, Consultant (1962)

What is Creso pharma’s Sector & Industry Classification?

Creso pharma (OTCMKTS:COPHF) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for Creso pharma?

Currently the number of employees working for Creso pharma is 0.

Where are Creso pharma's Headquarters?

Creso pharma (OTCMKTS:COPHF) is headquartered in WA, Australia.

What are Creso pharma's Address and Phone Number?

Creso pharma’s mailing address is 145 Stirling Highway, Nedlands, WA, Australia, 6009.
The company’s phone number is 61 8 9389 3180.

What is the official website for Creso pharma?

Creso pharma’s official website is